RUBEN HERNAEZ to Liver Cirrhosis
This is a "connection" page, showing publications RUBEN HERNAEZ has written about Liver Cirrhosis.
Connection Strength
3.963
-
Benefits and harms of hepatocellular carcinoma screening outreach in patients with cirrhosis: a multicenter randomized clinical trial. J Natl Cancer Inst. 2025 Feb 01; 117(2):262-269.
Score: 0.587
-
Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure. J Hepatol. 2020 12; 73(6):1425-1433.
Score: 0.425
-
?Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study. Ann Hepatol. 2017 Jan-Feb 2017; 16(1):16-20.
Score: 0.335
-
Access to Evaluation for Liver Transplantation in the Veterans Health Administration. Dig Dis Sci. 2025 Feb; 70(2):552-565.
Score: 0.145
-
Effectiveness of mailed outreach and patient navigation to promote HCC screening process completion: a multicentre pragmatic randomised clinical trial. Gut. 2024 Nov 11; 73(12):2037-2044.
Score: 0.144
-
Early Diagnostic Paracentesis Improves Outcomes of Hospitalized Patients With Cirrhosis and Ascites: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2024 Nov 01; 119(11):2259-2266.
Score: 0.141
-
Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers. Gut. 2024 05 10; 73(6):1015-1024.
Score: 0.139
-
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis. Gut. 2023 12 07; 73(1):156-165.
Score: 0.135
-
Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review. Saudi J Gastroenterol. 2024 01 01; 30(1):14-22.
Score: 0.135
-
Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
Score: 0.132
-
Definition, diagnosis and epidemiology of acute-on-chronic liver failure. Liver Int. 2025 Mar; 45(3):e15670.
Score: 0.132
-
MAFLD, HCC and the dilemma of (changing) terminology in liver diseases. Gut. 2023 01; 72(1):9-11.
Score: 0.119
-
Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance. Clin Gastroenterol Hepatol. 2022 12; 20(12):2818-2825.e1.
Score: 0.118
-
Serum testosterone levels and testosterone supplementation in cirrhosis: A systematic review. Liver Int. 2021 10; 41(10):2358-2370.
Score: 0.114
-
Hyperkalemia influences the outcome of patients with cirrhosis with acute decompensation (AD) and acute-on-chronic liver failure (ACLF). Dig Liver Dis. 2021 06; 53(6):738-745.
Score: 0.111
-
Reply to: "Model for end-stage liver disease-sodium in acute-on-chronic liver failure". J Hepatol. 2020 12; 73(6):1579-1580.
Score: 0.108
-
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium. J Hepatol. 2021 01; 74(1):200-219.
Score: 0.108
-
Depression and Anxiety Are Common Among Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2022 01; 20(1):194-203.e1.
Score: 0.108
-
Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 05; 19(5):987-995.e1.
Score: 0.107
-
Antitumour necrosis factor-a agents and development of new-onset cirrhosis or non-alcoholic fatty liver disease: a retrospective cohort. BMJ Open Gastroenterol. 2020; 7(1):e000349.
Score: 0.105
-
Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. J Hepatol. 2019 04; 70(4):639-647.
Score: 0.096
-
Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis. Hepatology. 2018 07; 68(1):7-9.
Score: 0.092
-
Hepatocellular carcinoma surveillance: The road ahead. Hepatology. 2017 03; 65(3):771-773.
Score: 0.084
-
Postoperative outcomes of acute-on-chronic liver failure in infants and children with biliary atresia. Pediatr Transplant. 2024 May; 28(3):e14736.
Score: 0.035
-
Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2024 Apr; 22(4):760-767.e1.
Score: 0.033
-
Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis. Hepatology. 2024 01 01; 79(1):107-117.
Score: 0.033
-
The novel SALT-M score predicts 1-year post-transplant mortality in patients with severe acute-on-chronic liver failure. J Hepatol. 2023 09; 79(3):717-727.
Score: 0.033
-
Reply to: "Acute-on-chronic liver failure in East-Asia: an underestimated issue with limited data". Gut. 2022 03; 71(3):657-658.
Score: 0.028
-
SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation. Contemp Clin Trials. 2021 05; 104:106367.
Score: 0.028
-
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021 01; 19(1):61-71.e15.
Score: 0.026
-
Renal Trajectory Patterns Are Associated With Postdischarge Mortality in Patients With Cirrhosis and Acute Kidney Injury. Clin Gastroenterol Hepatol. 2020 07; 18(8):1858-1866.e6.
Score: 0.026